New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 17, 2014
09:59 EDTWBMD, TQNT, TRXC, SWKS, SNDK, RFMD, PCL, NCLH, MHR, KRO, JAZZ, HAFC, GBDC, FMI, CVA, BNFT, ADHD, ACOR, ACRXOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AcelRx (ACRX) initiated with a Buy at Canaccord... Acorda Therapeutics (ACOR) initiated with a Hold at Canaccord... Alcobra (ADHD) initiated with a Buy at Canaccord... Benefitfocus (BNFT) initiated with a Market Perform at William Blair... Cameron (CAM) initiated with a Buy at Gabelli... Covanta (CVA) initiated with an Outperform at Macquarie... Foundation Medicine (FMI) initiated with a Market Perform at William Blair... Golub Capital (GBDC) initiated with an Outperform at Raymond James... Hanmi Financial (HAFC) initiated with an Outperform at Raymond James... Jazz Pharmaceuticals (JAZZ) initiated with a Buy at Canaccord... Kronos Worldwide (KRO) initiated with a Reduce at SunTrust... Magnum Hunter (MHR) initiated with a Hold at Maxim... Norwegian Cruise Line (NCLH) initiated with a Buy at Longbow... Plum Creek Timber (PCL) initiated with an Outperform at RBC Capital... RF Micro Devices (RFMD) initiated with a Market Perform at BMO Capital... SanDisk (SNDK) assumed with an Overweight at Piper Jaffray... Skyworks (SWKS) initiated with a Market Perform at BMO Capital... TransEnterix (TRXC) initiated with a Buy at Sterne Agee... TriQuint (TQNT) initiated with a Market Perform at BMO Capital... WebMD (WBMD) initiated with an Outperform at William Blair.
News For ACRX;ACOR;ADHD;BNFT;CVA;FMI;GBDC;HAFC;JAZZ;KRO;MHR;NCLH;PCL;RFMD;SNDK;SWKS;TRXC;TQNT;WBMD From The Last 14 Days
Check below for free stories on ACRX;ACOR;ADHD;BNFT;CVA;FMI;GBDC;HAFC;JAZZ;KRO;MHR;NCLH;PCL;RFMD;SNDK;SWKS;TRXC;TQNT;WBMD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 8, 2014
08:17 EDTJAZZJazz Pharmaceuticals executing on all cylinders, says Stifel
Following management meetings, Stifel reiterates its Buy rating and $195 price target on Jazz Pharmaceuticals given growth opportunities and sustainability of its current portfolio. The firm agrees with the Xyrem franchise expansion strategies through new patient capture near-term, and longer-term, the addition of complementary wakefulness products.
08:08 EDTSNDKSanDisk initiated with an Outperform at FBN Securities
Target $120.
07:21 EDTJAZZJazz looks more attractive for Allergan than Salix, says Wells Fargo
Subscribe for More Information
September 5, 2014
17:03 EDTRFMD, TQNTTriQuint shareholders approve merger-of-equals with RF Micro Devices
Subscribe for More Information
12:50 EDTFMIFoundation Medicine management to meet with JPMorgan
Subscribe for More Information
11:40 EDTJAZZJazz Pharmaceuticals calls active on renewed takeover speculation
Subscribe for More Information
11:00 EDTJAZZRumor: Jazz Pharmaceuticals strength attributed to renewed takeover speculation
Subscribe for More Information
10:05 EDTSNDKOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:31 EDTSNDKSanDisk acquisition positive, says Bernstein
After SanDisk bought Fusion-io, Bernstein thinks the deal plugs the gap in the company's Enterprise SSD market and will accelerate its growth in this new market. The firm expects the deal to be dilutive to SanDisk until 3Q15. It keeps an Outperform rating on the shares.
09:13 EDTTQNT, RFMDRF Micro Devices holders approve merger of equals with TriQuint
Subscribe for More Information
08:01 EDTSNDKSanDisk upgraded at Morgan Stanley
As previously reported, Morgan Stanley upgraded SanDisk to Overweight from Equal Weight. The firm upgraded shares based on valuation and a solid NAND supply/demand balance for 2015-2016.
06:22 EDTPCLPlum Creek Timber initiated with an Overweight at JPMorgan
Target $46.
05:57 EDTSNDKSanDisk upgraded to Overweight from Equal Weight at Morgan Stanley
September 4, 2014
10:29 EDTNCLHOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:40 EDTADHDAlcobra should be bought ahead of data, says Roth Capital
Subscribe for More Information
06:55 EDTSNDKSanDisk reinstated with a Buy at Deutsche Bank
Deutsche Bank reinstated shares of SanDisk with a Buy rating citing limited NAND supply risk in the next 12 months and the demand pickup from SSDs and smartphones. The firm has a $110 price target for shares.
05:41 EDTNCLHNorwegian Cruise Line downgraded to Neutral from Buy at Goldman
Subscribe for More Information
September 3, 2014
17:34 EDTPCLPlum Creek Timber initiated with a Market Perform at BMO Capital
Subscribe for More Information
09:29 EDTSNDKMicron, SanDisk have positive read though from Samsung proxy, says Sterne Agee
Subscribe for More Information
07:47 EDTJAZZJazz Pharmaceuticals management to meet with Deutsche Bank
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use